Search Result "lipid-lowering drugs (LLDs)"
The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 4 Year: 2018 Page: 368-375
Author(s): Abdullah Shehab,Khalid Al-Rasadi,Mohamed Arafah,Ali T. Al-Hinai,Wael Al Mahmeed,Akshaya Srikanth Bhagavathula,Omer Al Tamimi,Shorook Al Herz,Faisal Al Anazi,Khalid Al Nemer,Othman Metwally,Akram Alkhadra,Mohammed Fakhry,Hossam Elghetany,Abdel Razak Medani,Afzal Hussein Yusufali,Obaid Al Jassim,Omar Al Hallaq,Fahad Omar Ahmed S. Baslaib,Mahmoud Alawadhi,Haitham Amin,Khamis Al-Hashmi,Abderrahim Oulhaj
Past and Present Drug Development for Alzheimers Disease
Ebook: Frontiers in Clinical Drug Research - Alzheimer Disorders
Volume: 7 Year: 2018
Author(s): Pratap Kumar Sahu,Prashant Tiwari,Shakti Ketan Prusty,Bharat Bhusan Subudhi
Doi: 10.2174/9781681085609118070009
Gender Disparity in Lipid Target Achievements in High and Very High Atherosclerotic Cardiovascular Disease Risk Patients in the Arabian Gulf
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 51-58
Author(s): Ibrahim Al-Zakwani,Abdullah Shehab,Ali T. Al-Hinai,Wael Al Mahmeed,Mohamed Arafah,Omer Al Tamimi,Mahmoud Al Awadhi,Faisal Al Anazi,Haitham Amin,Khalid Al Nemer,Shorook Al Herz,Othman Metwally,Akram Alkhadra,Mohammed Fakhry,Hossam Elghetany,Abdel Razak Medani,Afzal Hussein Yusufali,Obaid Al Jassim,Omar Al Hallaq,Fahad Omar,Ahmed S. Baslaib,Khalid Al Waili,Khamis Al Hashmi,Vasilios Athyros,Khalid Al Rasadi
Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery
Journal: Recent Patents on Nanotechnology
Volume: 9 Issue: 3 Year: 2015 Page: 150-177
Author(s): Sunil Khatak,Harish Dureja
Applications of Polymeric Nanocapsules in Field of Drug Delivery Systems
Journal: Current Drug Discovery Technologies
Volume: 8 Issue: 3 Year: 2011 Page: 173-187
Author(s): Xinyu Rong, Yinghua Xie, Xiaomei Hao, Tao Chen, Yingming Wang, Yuanyuan Liu
The NLRP3 Inflammasome as a Target for Antiinflammatory Drugs
Ebook: The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response
Volume: 1 Year: 2024
Author(s):
Doi: 10.2174/9789815223941124010009
Dendrimers and the Development of New Complex Nanomaterials for Biomedical Applications
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 29 Year: 2012 Page: 4913-4928
Author(s): K. Gardikis,M. Micha-Screttas,C. Demetzos,B. R. Steele
Eosinophilopoiesis at the Cross-Roads of Research on Development, Immunity and Drug Discovery
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2007 Page: 1925-1939
Author(s): P. Xavier Elsas, M.I. Gaspar Elsas
New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 6 Year: 2005 Page: 393-419
Author(s): Christian Hafner, Albrecht Reichle, Thomas Vogt
Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4405-4423
Author(s): Ganesh R. Kokil, Prarthana V. Rewatkar, Arunima Verma, Suresh Thareja, Suresh R. Naik